Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.01% |
| 2 | Technology | 7.75% |
| 3 | Financials | 7.01% |
| 4 | Consumer Discretionary | 6.9% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Ameris Bancorp
ABCB
$5.74B
| $7.18M | 0.01% |
304,364
+284,191
| +1,409% | +$6.67M |
|
1427
MDU Resources
MDU
$4.2B
| $7.16M | 0.01% |
849,303
+764,931
| +907% | +$6.36M |
|
1428
PUT
Zimmer Biomet
ZBH
$19.1B
| $7.16M | 0.01% |
+61,800
| New | +$7.12M |
|
1429
Artisan Partners
APAM
$3.1B
| $7.15M | 0.01% |
+220,087
| New | +$6.1M |
|
1430
PUT
Elevance Health
ELV
$86.5B
| $7.15M | 0.01% |
27,200
+19,200
| +240% | +$5.12M |
|
|
BPYU
1431
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $7.14M | 0.01% |
716,629
+537,570
| +300% | +$5.41M |
|
|
WWE
1432
DELISTED
World Wrestling Entertainment
WWE
| $7.13M | 0.01% |
164,109
-410,254
| -71% | -$17.6M |
|
1433
Honda
HMC
$41.3B
| $7.13M | 0.01% |
278,956
+269,582
| +2,876% | +$6.55M |
|
1434
Atmos Energy
ATO
$28.3B
| $7.13M | 0.01% |
71,577
-131,988
| -65% | -$13.3M |
|
|
FEAC.WS
1435
CALL
DELISTED
Flying Eagle Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A com
FEAC.WS
| $7.12M | 0.01% |
+648,575
| New | +$1.36M |
|
|
PGRE
1436
DELISTED
Paramount Group
PGRE
| $7.1M | 0.01% |
+920,619
| New | +$7.77M |
|
1437
PUT
Automatic Data Processing
ADP
$112B
| $7.09M | 0.01% |
47,600
-33,600
| -41% | -$4.81M |
|
1438
CALL
Valero Energy
VLO
$98B
| $7.06M | 0.01% |
+120,000
| New | +$7.17M |
|
1439
Cabaletta Bio
CABA
$546M
| $7.04M | 0.01% |
631,904
+239,089
| +61% | +$1.83M |
|
1440
First American
FAF
$7.48B
| $7.04M | 0.01% |
146,509
+42,895
| +41% | +$2.03M |
|
|
JBGS
1441
JBG SMITH
JBGS
$741M
| $7.02M | 0.01% |
237,538
+229,264
| +2,771% | +$7.1M |
|
1442
Pacific Biosciences
PACB
$472M
| $7.02M | 0.01% |
2,035,463
-315,834
| -13% | -$1.08M |
|
1443
Eastman Chemical
EMN
$8.23B
| $7.01M | 0.01% |
100,710
-560,044
| -85% | -$35.3M |
|
1444
Central Pacific Financial
CPF
$969M
| $7M | 0.01% |
436,557
+99,842
| +30% | +$1.59M |
|
1445
Agios Pharmaceuticals
AGIO
$2.02B
| $6.99M | 0.01% |
130,752
-147,176
| -53% | -$6.81M |
|
1446
Fabrinet
FN
$15.5B
| $6.99M | 0.01% |
112,017
+107,040
| +2,151% | +$6.57M |
|
|
THWWW
1447
CALL
DELISTED
Target Hospitality Corp. Warrant expiring 3/15/2024
THWWW
| $6.96M | 0.01% |
4,120,000
+1,129,200
| +38% | +$249K |
|
1448
CBRE Group
CBRE
$43.9B
| $6.96M | 0.01% |
153,884
+144,201
| +1,489% | +$6.22M |
|
1449
DraftKings
DKNG
$12.8B
| $6.94M | 0.01% |
208,749
-937,369
| -82% | -$25.9M |
|
|
RPTX
1450
DELISTED
Repare Therapeutics
RPTX
| $6.92M | 0.01% |
+223,244
| New | +$7.17M |
|
Similar funds
Israel Englander's Q2 2020 Portfolio in Review
As of Q2 2020, Israel Englander held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 9% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Israel Englander's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Israel Englander added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Israel Englander's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Israel Englander fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Israel Englander's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Israel Englander opened 1,140 new positions and closed 798 in Q2 2020.
- Israel Englander's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.